MOBIC

This brand name is authorized in United States. It is also authorized in Australia, Ecuador, Finland, France, Hong Kong SAR China, Italy, Japan, New Zealand, Singapore, South Africa, Tunisia.

Active ingredients

The drug MOBIC contains one active pharmaceutical ingredient (API):

1	Meloxicam UNII VG2QF83CGL - MELOXICAM
	Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam family, with anti-inflammatory, analgesic and antipyretic properties. The anti-inflammatory activity of meloxicam has been proven in classical models of inflammation. As with other NSAID, its precise mechanism of action remains unknown. However, there is at least one common mode of action shared by all NSAID (including meloxicam): inhibition of the biosynthesis of prostaglandins, known inflammation mediators.
	Read more about Meloxicam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MOBIC Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AC06	Meloxicam	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8561N, 8562P, 8887R, 8888T
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.377-1-05-04, 21.645-1-09-04, 27.019-05-06
FI	Lääkealan turvallisuus- ja kehittämiskeskus	383190, 383208, 383216, 383224
FR	Base de données publique des médicaments	60821012, 65217119, 67044235
HK	Department of Health Drug Office	41788, 41789
IT	Agenzia del Farmaco	031985068, 031985157
JP	医薬品医療機器総合機構	1149035F1020, 1149035F2027
NZ	Medicines and Medical Devices Safety Authority	7389
SG	Health Sciences Authority	09554P
TN	Direction de la Pharmacie et du Médicament	5213112
US	FDA, National Drug Code	0597-0029, 0597-0030, 55289-618, 80425-0041, 80425-0042, 80425-0043, 80425-0044, 80425-0045
ZA	Health Products Regulatory Authority	29/3.1/0422